Good quality medicines, given at the right time, can save the lives of pregnant and recently pregnant women and their newborns. New evidence synthesis suggests that in many healthcare settings around the world, life-threatening women are
Maternal complications are given poor quality medicines – jeopardizing their lives and well-being.
Systematic systematic reviews by staff of the Department of Sexual and Reproductive Health and Research, including WHO, HRP
And partners published in PLOS ONE
Maternal mortality rate
It is both sad and unacceptable that so many women, especially those living in low and middle income countries, continue to die due to health complications related to pregnancy, childbirth and childbirth.
Period. The most recent estimates showed that approximately 810 women died every day in 2017 from preventable causes related to pregnancy and childbirth.
Correct treatment can prevent
Repeated life-related maternal complications include post-partum haemorrhage, pre-eclampsia / eclampsia, and sepsis. With timely and effective care and medications, any serious consequences due to these
Complications can often be avoided. Ototonics (drugs used to stop bleeding such as oxytocin, especially for postpartum haemorrhage) are effective in preventing post-partum haemorrhage. Antibiotics may be administered during delivery or after birth.
Preventing or treating sepsis for both women and their newborns. And magnesium sulfate may help prevent and / or treat eclampsia. These are medical options that are both inexpensive and effective.
"Out of specification" and poor quality medicines
Concerns about the negative impact on the health of substandard and false drugs (especially in the form of "out of specification" drugs) are low- and –
Middle Income Countries. However, new systematic reviews show that in many health care settings in low and middle income countries, poor quality versions of these drugs are often provided. The findings suggest that this problem may contribute
Persistence of high numbers of serious complications and deaths due to POS partum haemorrhage, eclampsia and sepsis in low and middle income countries.
New studies have shown that about half (48.9%) of all uterus
Samples of drugs failed to assess quality. 1 in 7 injectable antibiotic samples (13%) and 1 in 29 magnesium sulfate samples (3.4%) were of low quality.
Approximately the samples evaluated since 2011 were collected, indicating that it
The current is a matter of global concern that needs immediate attention. The study also looked at differences in the quality of drugs between the private and public sector, and found that in general, higher failure rates were in the private sector.
This finding requires national procurement bodies or private providers to purchase drugs that comply with WHO's prequalification, or similar stringent requirements.
Quality and dignity
Every woman has the right to quality care before, during and after pregnancy and delivery. The informed provision of good quality medicines, at the right time, is important to ensure high quality and dignified care
Women and their newborns.
Health care providers need to be able to use good quality medicines for the proper care of women. They should also receive proper training of how and when to give these medicines. This is
The key is that they & # 39; do no harm & # 39; Let's work to maintain the Hippocratic oath.
Mariana Widmer, a scientist and an author at WHO and HRP, and an author of the paper demonstrates, "Health care workers need to be able to know that they are actually taking care of women, and that pregnancy and childbirth Effectively treating any health complications. We
There is a need to ensure that they receive training to provide medicines, and that the medicines are always of good quality.